background
fibroblast
growth
factor
promis
drug
candid
combat
metabol
diseas
howev
highlevel
express
purif
recombin
escherichia
coli
e
coli
difficult
form
inclus
bodi
bacteria
make
difficult
purifi
obtain
high
concentr
bioactiv
overcom
problem
fuse
sumo
small
ubiquitinrel
modifi
polymeras
chain
reaction
pcr
express
fuse
gene
e
coli
result
induc
iptg
express
high
level
concentr
reach
total
protein
exceed
solubl
protein
fuse
protein
purifi
deae
sepharos
ff
ninta
affin
chromatographi
cleav
sumo
proteas
puriti
high
perform
liquid
chromatographi
hplc
shown
higher
low
endotoxin
level
euml
result
vivo
anim
experi
show
produc
use
method
could
decreas
concentr
plasma
glucos
diabet
rat
streptozotocin
stz
inject
conclus
studi
demonstr
sumo
fuse
abl
promot
solubl
express
latter
e
coli
make
conveni
purifi
previous
may
better
method
produc
pharmaceut
research
develop
background
potent
regul
glucos
homeostasi
origin
identifi
hormon
stimul
glucos
uptak
adipocyt
induc
secret
liver
upon
fast
act
adipos
tissu
induc
metabol
adapt
fast
specif
stimul
lipolysi
adipocyt
process
releas
fatti
acid
bloodstream
reach
liver
fatti
acid
convert
keton
free
prolif
tumorigen
effect
document
member
fgf
famili
system
administr
reduc
plasma
glucos
fructosamin
triglycerid
insulin
glucagon
diabet
rhesu
monkey
administr
led
signific
improv
lipoprotein
profil
lower
lowdens
cholesterol
rais
highdens
cholesterol
well
caus
weight
loss
anim
recent
year
describ
potenti
new
drug
candid
combat
metabol
diseas
howev
produc
tradit
techniqu
plasmid
recombin
e
coli
yield
disappoint
result
kharitonenkov
experi
shown
recombin
accumul
form
inclus
bodi
transform
e
coli
previou
experi
also
show
without
fusion
express
easili
form
inclus
bodi
difficult
produc
bioactiv
protein
data
shown
inclus
bodi
need
denatur
anneal
purifi
mani
chromatographi
column
sumo
small
ubiquitinrel
modifi
protein
coval
attach
remov
specif
protein
substrat
eukaryot
cell
sumoyl
revers
posttransl
modif
process
shown
involv
mani
cellular
process
includ
nuclearcytosol
transport
apoptosi
protein
activ
protein
stabil
stress
respons
cell
cycl
progress
recent
year
sumo
becom
effect
biotechnolog
tool
fusion
system
enhanc
solubl
express
protein
decreas
proteolyt
degrad
could
achiev
tradit
express
system
sumo
posttransl
enzymat
cleav
desir
protein
sumo
ctermin
hydrolasesisopeptidas
protein
sar
viru
protein
egf
metallothionein
success
express
purifi
use
fusion
strategi
recent
ren
express
use
commerci
vector
contain
sumo
tag
show
sumo
promot
solubl
express
e
coli
howev
higher
level
puriti
attain
use
ninta
affil
purif
alon
thu
clone
sumo
fragment
construct
express
plasmid
contain
sumo
human
result
show
novel
method
protein
express
promot
significantli
higher
level
make
easier
dissolv
solubl
fraction
purif
produc
nativ
ntermin
recombin
protein
bioactiv
preserv
synthes
fusion
gene
compos
sumo
fourteen
special
primer
design
tabl
synthesi
strategi
describ
figur
detail
procedur
includ
materi
method
pcr
product
shown
figur
final
pcr
product
digest
two
restrict
enzym
ndei
xhoi
clone
express
vector
sequenc
recombin
plasmid
confirm
autom
dna
sequenc
result
show
sequenc
bp
sumo
bp
human
bp
conform
prior
sequenc
sequenc
submit
genbank
databas
access
number
recombin
inocul
fresh
luriabertani
lb
medium
incub
shake
incub
od
isopropyl
dthiogalactosid
iptg
ad
final
concentr
mm
induct
express
recombin
bacteri
cell
collect
centrifug
lyse
sonic
supernat
pellet
collect
subject
sdspolyacrylamid
gel
electrophoresi
sdspage
analysi
result
show
molecular
weight
express
product
kda
correspond
predict
size
target
protein
total
cellular
protein
solubl
fraction
reach
total
express
recombin
protein
figur
accord
isoelectr
point
fusion
protein
deae
sepharos
ff
chosen
purif
sdspage
result
show
host
protein
remov
purifi
deae
sepharos
ff
column
furthermor
ninta
affin
column
chosen
purif
protein
without
tag
remov
ninta
resin
use
pb
contain
mm
mm
imidazol
elut
use
pb
contain
mm
imidazol
sdspage
analysi
sampl
taken
step
show
puriti
reach
figur
recent
year
mani
report
concern
sumo
express
fusion
tag
express
level
fusion
protein
contain
metallothionein
gst
sumo
total
supernat
protein
organ
data
show
concentr
solubl
protein
express
effici
may
affect
molecular
weight
amino
acid
constitut
function
protein
etc
far
protein
isol
perform
twostep
purif
result
puriti
reach
result
show
twostep
purif
help
improv
puriti
success
one
step
ninta
purif
well
inclus
bodi
purif
target
protein
fuse
directli
cterminu
sumo
cleavag
sumo
proteas
result
releas
target
protein
desir
ntermin
amino
acid
sequenc
studi
prepurifi
fusion
protein
dilut
cleav
sumo
proteas
lysat
purifi
ninta
resin
sumo
sumo
proteas
contain
tag
affili
ninta
resin
elut
ninta
column
result
show
highli
purifi
sdspage
figur
could
react
human
polyclon
antibodi
western
blot
figur
hplc
analysi
target
protein
show
major
peak
retent
time
min
puriti
exceed
figur
next
test
endotoxin
level
three
differ
batch
purifi
result
less
euml
consid
accept
compar
commerci
avail
protein
level
also
accord
standard
inject
biolog
list
chines
pharmacopeia
also
suggest
puriti
method
meet
requir
pharmaceut
research
vivo
order
confirm
authent
target
protein
subject
malditof
mass
spectroscopi
analysi
ntermin
amino
acid
sequenc
analysi
molecular
weight
analyz
malditof
mass
spectroscopi
kda
close
kda
theoret
molecular
weight
moreov
accord
sequenc
result
first
five
amino
acid
nterminu
hpipd
conform
nativ
vivo
bioactiv
construct
diabet
rat
model
describ
materi
method
test
effect
diabet
rat
diabet
rat
treat
daili
two
week
high
medium
low
dosag
treatment
produc
signific
chang
compar
control
anim
statist
result
describ
use
column
graph
figur
see
chang
plasma
glucos
level
show
signific
differ
compar
control
inject
three
dose
low
p
vs
control
medium
p
vs
control
high
p
vs
control
result
also
show
act
figur
sdspage
analysi
sumo
proteas
assay
western
blot
purifi
digest
sumo
proteas
overnight
seen
figur
cut
sumo
proteas
protein
molecular
weight
marker
purifi
fusion
protein
treatment
sumo
proteas
western
blot
analysi
perform
describ
materi
method
immunoacit
purifi
antihuman
antibodi
shown
figur
standard
peprotech
comp
purifi
figur
hplc
analysi
purifi
puriti
elut
ninta
sepharos
column
evalu
hplc
analysi
use
column
seen
chromatogram
yaxi
indic
absorb
xaxi
repres
elut
time
min
main
peak
observ
min
correspond
dosedepend
manner
reduc
plasma
glucos
diabet
rat
high
dose
result
better
effect
two
dose
high
dose
lower
circul
glucos
mmoll
mmoll
compar
insulin
display
signific
effect
decreas
plasma
glucos
c
p
consid
signific
differ
preand
posttreat
differ
effect
might
due
differ
mechan
decreas
plasma
glucos
insulin
contrast
insulin
known
function
via
transloc
primarili
act
upregul
cellular
mani
experi
also
document
could
promot
glucos
uptak
adipocyt
cell
well
reduc
plasma
glucos
triglycerid
anim
model
type
diabet
mous
monkey
howev
differ
reduct
blood
glucos
level
attribut
differ
anim
genotyp
treatment
obob
mice
dose
significantli
lower
blood
glucos
compar
vehicl
treatment
day
administr
day
drug
administr
treatment
reduc
fast
blood
glucos
also
improv
insulin
sensit
obob
mice
notabl
dose
lower
mean
fast
plasma
glucos
overtli
diabet
level
near
normal
administ
week
studi
dose
decreas
glucos
level
diabet
mice
administr
result
dosedepend
reduct
circul
level
glucos
studi
demonstr
fuse
sumo
solubl
express
increas
e
coli
form
also
conveni
isol
previous
describ
form
novel
molecular
chaperon
domain
sumo
increas
yield
recombin
protein
make
easier
dissolv
solubl
fraction
protein
purif
strategi
use
sourc
refer
express
purif
protein
dna
polymeras
restrict
enzym
ndei
xhoi
purchas
takara
compani
japan
pcr
purif
kit
gel
extract
kit
plasmid
miniprep
kit
obtain
omega
compani
usa
express
vector
produc
engin
research
center
bioreactor
pharmaceut
develop
ministri
educ
jilin
agricultur
univers
china
deae
sepharos
ff
column
sepharos
column
purchas
ge
healthcar
sweden
ninta
agaros
obtain
invitrogen
usa
human
protein
purchas
peprotech
compani
korea
antibodi
purchas
santa
cruz
biotechnolog
compani
usa
dr
yadong
huang
ji
nan
univers
gracious
suppli
us
sumo
proteas
treatment
treatment
figur
effect
reduc
plasma
glucos
diabet
rat
stz
treat
diabet
rat
inject
differ
dose
daili
two
week
control
nacl
low
mgkg
medium
mgkg
high
mgkg
insulin
per
rat
result
show
act
dosedepend
manner
reduc
plasma
glucos
diabet
rat
high
dose
demonstr
better
effect
dose
compar
insulin
display
signific
effect
decreas
plasma
glucos
p
b
p
c
p
consid
signific
differ
posttreat
compar
pretreat
strategi
synthes
fusion
gene
illustr
figur
core
fragment
sumo
first
obtain
polymeras
chain
reaction
pcr
perform
follow
reaction
mixtur
contain
dntp
pcr
buffer
incub
min
dna
polymeras
ad
reaction
temperatur
decreas
anneal
step
conduct
min
elong
done
sec
get
fragment
likewis
react
form
fragment
b
primer
form
fragment
c
primer
form
fragment
use
b
common
templat
forward
revers
primer
reaction
denatur
min
follow
consecut
cycl
denatur
anneal
extens
min
final
singl
extens
min
get
fragment
fragment
c
use
creat
fragment
n
final
fragment
n
use
form
fragment
accord
previous
describ
procedur
use
plasmid
contain
sumo
fragment
templat
pa
sumo
linker
forward
revers
primer
sumolink
gener
use
sumolink
fragment
common
templat
pa
forward
revers
primer
fulllength
construct
creat
use
pcr
reaction
procedur
describ
fusion
gene
digest
ndei
xhoi
ligat
previous
digest
creat
new
express
vector
authent
insert
fragment
confirm
restrict
enzym
analysi
autom
dna
sequenc
recombin
plasmid
transform
escherichia
coli
cell
express
follow
singl
transform
coloni
grown
ml
lb
medium
pepton
yeast
extract
sodium
chlorid
ph
contain
ampicillin
shake
rpm
overnight
growth
cultur
transfer
ml
fresh
lb
medium
exponenti
growth
od
valu
reach
iptg
ad
cultur
final
concentr
mmol
l
cultur
incub
anoth
hour
shake
rpm
separ
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
amount
fusion
protein
yield
measur
densitomet
scan
cell
medium
induc
differ
condit
harvest
centrifug
rpm
min
cell
pellet
suspend
mmoll
pb
buffer
dissolv
sonic
suspens
centrifug
rpm
min
clear
supernat
collect
solubl
fraction
remain
pellet
insolubl
fraction
contain
inclus
bodi
resuspend
equal
volum
lysi
buffer
solubl
insolubl
fraction
analyz
sdspage
cell
lysat
purifi
deaesepharos
ff
column
chromatographi
eluat
buffer
contain
differ
concentr
nacl
mmoll
ph
follow
purif
ninta
resin
invitrogen
ninta
resin
wash
wash
buffer
mmoll
pb
contain
mm
imidazol
mm
nacl
ph
od
effluent
reach
base
line
contamin
protein
elut
column
wash
buffer
ii
mmoll
pb
contain
mm
imidazol
mm
nacl
ph
final
histag
protein
collect
column
elut
buffer
mmoll
pb
contain
mm
imidazol
mm
nacl
ph
sampl
taken
elut
peak
pool
puriti
assess
use
sdspage
concentr
evalu
bradford
method
elut
fusion
protein
dilut
concentr
mgml
ten
unit
sumo
proteas
ad
dilut
mixtur
incub
high
salt
buffer
mm
trishcl
ph
nacl
mm
dtt
hr
follow
incub
mixtur
load
onto
ninta
resin
column
obtain
concentr
ultrafiltr
sumo
sumo
proteas
stay
bound
ninta
resin
elut
column
wash
resin
elut
buffer
desalt
sepharos
column
immunogen
activ
purifi
assay
western
blot
total
cellular
protein
boil
equal
volum
sampl
load
buffer
trishcl
buffer
ph
contain
glycerol
sd
bromophenol
blue
protein
sampl
electrophores
polyacrylamid
gel
contain
sd
protein
electrophoret
transfer
onto
pvdf
membran
overnight
exposur
bsa
block
nonspecif
bind
membran
incub
polyclon
antibodi
santa
cruz
biotechnolog
inc
membran
wash
incub
dilut
secondari
hrpconjug
antibodi
rabbit
antigoat
igg
amersham
bioscienc
corp
immunoreact
band
visual
use
dab
kit
boshid
inc
wuhan
china
high
perform
liquid
chromatographi
hplc
analysi
purifi
desalt
load
onto
column
elut
carri
use
linear
gradient
acetonitril
flow
rate
mlmin
presenc
trifluoroacet
acid
tfa
fraction
contain
pool
subject
ntermin
amino
acid
sequenc
amino
acid
composit
analysi
malditof
mass
spectroscopi
analysi
concentr
evalu
bradford
method
endotoxin
concentr
estim
quantit
use
chromogen
tachypleu
amebocyt
lysat
tal
endpoint
assay
kit
describ
manufactur
zhanjiang
c
biolog
ltd
china
assay
perform
accord
kit
protocol
vivo
activ
assay
procedur
involv
anim
care
describ
approv
institut
anim
care
use
committe
jilin
agricultur
univers
perform
accord
institut
guidelin
anim
experi
male
wistar
adult
rat
weight
g
randomli
divid
high
fat
diet
group
hfd
n
common
diet
group
nc
n
fed
high
fat
diet
two
month
hfd
group
anim
given
periton
inject
mgkg
streptozotocin
stz
sigma
usa
nc
group
given
equival
volum
citric
acid
buffer
one
week
later
blood
collect
fast
plasma
glucos
fpg
assay
stz
treat
rat
fpg
mmoll
chosen
type
diabet
model
n
subsequ
diabet
rat
divid
five
group
n
diabet
rat
treat
mgkg
group
high
dose
diabet
rat
treat
mgkg
group
medium
dose
diabet
rat
treat
mgkg
group
low
dose
diabet
rat
treat
insulin
uday
group
posit
control
diabet
rat
treat
nacl
group
neg
control
addit
nc
rat
constitut
blank
control
group
drug
given
subcutan
inject
daili
two
week
valu
express
mean
sem
mean
valu
comparison
two
group
perform
use
student
test
signific
differ
consid
p
